|
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
    
 |
|
 Frequently Asked Questions Before You Start Taking REPRONEX®
What is REPRONEX®? Taking and Storing REPRONEX®
How is REPRONEX® supplied? More About REPRONEX®—
Are there side effects? Click here to print the REPRONEX® FAQ page REPRONEX® is a mixture of human follicle-stimulating hormone (FSH) and luteinizing hormone (LH) activity, the most important hormones for inducing the growth of the follicles that produce ova (eggs). REPRONEX® is classified as a human menopausal gonadotropin (hMG) or "menotropin." Menotropins—injectable hormones that control the reproductive function—are one of the most widely used types of infertility medication. REPRONEX® stimulates egg follicles to grow within the ovaries. Who should prescribe REPRONEX® and monitor my care? REPRONEX® should be used only by physicians who are thoroughly familiar with infertility treatment and have adequate monitoring facilities. A reproductive endocrinologist, who is most knowledgeable about fertility treatments, should be managing your care to ensure the best outcome. For a referral to a recognized reproductive endocrinologist, contact the American Society of Reproductive Medicine at 205-978-5000, or online at www.asrm.org. REPRONEX® should not be used by women who are pregnant or have primary ovarian failure, uncontrolled thyroid and adrenal dysfunction, or an organic intracranial lesion such as a pituitary tumor. Also, women who have abnormal bleeding of undetermined origin, ovarian cysts or enlargement not due to polycystic ovary syndrome, or prior hypersensitivity to menotropins should not use this product. Women whose cause of infertility is other then anovulation should not use REPRONEX®. REPRONEX® comes in a vial as a sterile powder along with the accompanying sterile diluent. Your doctor may recommend using a specified amount of diluent to dissolve one or more vials of REPRONEX®. REPRONEX® is usually administered by subcutaneous (SC) injection but can also be given by intramuscular injection (IM). SC administration is often easier to use, however, depending on your specific needs, your doctor may recommend either the SC or IM route of administration. After you and your partner undergo a thorough exam to determine the cause of infertility, your doctor will then recommend a course of action and may prescribe REPRONEX®. Treatment usually begins a few days after your period and may continue daily for 7 to 12 days, depending on how long it takes your follicles to mature. Undissolved REPRONEX®, in powder form, should be stored in the refrigerator or at room temperature and is good until the date printed on the vial. The product should be protected from light, so store it in its box if possible. Once REPRONEX® has been dissolved, it should be used immediately and any unused REPRONEX® should be discarded. REPRONEX®, like all gonadotropins, may produce side effects. Among the most common are abdominal pain, abdominal cramping, nausea, headache, ovarian disease, vaginal hemorrhage, and enlarged abdomen. A less common but potentially serious side effect associated with all gonadotropin therapy is ovarian hyperstimulation syndrome (OHSS). OHSS occurs in approximately 6% of patients who take BRAVELLE® Please see Full Prescribing Information. Have clinical studies been conducted to demonstrate the effectiveness of REPRONEX®? Yes. Please see Full Prescribing Information. REPRONEX®, in conjunction with hCG, is indicated for multiple follicular development (controlled ovarian stimulation) and ovulation induction in patients who have previously received pituitary suppression.
Important Safety Information Click here to see Full Prescribing Information for REPRONEX®.
|
||||||
|
|
|
